February 25, 2021
Recently, the Military Health System website, Health.mil, covered a study of COVID-19 antibodies by an HJF supported research center.
From the article: "This study is designed to prevent the development of illness in people who have been exposed to COVID-19 in care homes and sites with enhanced risk of disease transmission, under the sponsorship of AstraZeneca with support from the U.S. health information technology and clinical research firm IQVIA. IDCRP is supported through a cooperative agreement with The Henry M. Jackson Foundation for the Advancement of Military Medicine."
